Public Employees Retirement System of Ohio acquired a new position in shares of Kamada Ltd. (NASDAQ:KMDA – Free Report) in the 3rd quarter, HoldingsChannel reports. The institutional investor acquired 14,270 shares of the biotechnology company’s stock, valued at approximately $77,000.
Separately, Plato Investment Management Ltd bought a new stake in shares of Kamada during the 3rd quarter valued at approximately $117,000. 20.38% of the stock is owned by hedge funds and other institutional investors.
Kamada Stock Performance
Shares of NASDAQ:KMDA opened at $5.90 on Monday. The company has a market capitalization of $339.13 million, a P/E ratio of 21.07 and a beta of 0.99. Kamada Ltd. has a fifty-two week low of $4.74 and a fifty-two week high of $6.53. The company’s 50-day moving average is $5.78 and its 200 day moving average is $5.55.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on KMDA
Kamada Company Profile
Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its commercial products include KAMRAB/KEDRAB for treating prophylaxis of rabies; CYTOGAM for Prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; KAMRHO (D) IV for immune thermobocytopunic purpura; and Echis coloratus and Vipera palaestinae Antiserum for the treatment of snake bite.
Featured Articles
- Five stocks we like better than Kamada
- What is a Dividend King?
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- What Are Earnings Reports?
- CarMax Gets in Gear: Is Now the Time to Buy?
- 10 Best Airline Stocks to Buy
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Want to see what other hedge funds are holding KMDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kamada Ltd. (NASDAQ:KMDA – Free Report).
Receive News & Ratings for Kamada Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kamada and related companies with MarketBeat.com's FREE daily email newsletter.